Provenance du réseau au premier degré de Anurag Kondapalli
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Nanomosaic Inc.
 Nanomosaic Inc. Miscellaneous Commercial ServicesCommercial Services Nanomosaic Inc. is a pioneering biotechnology company based in New York, NY. Nanomosaic Inc. develops innovative tools and technologies for biomarker detection and analysis. The company's flagship product, the Nanomosaic Tessie™ system, is a high-throughput platform for protein biomarker detection that allows researchers to analyze multiple samples simultaneously with high sensitivity and specificity. The system is designed to accelerate the discovery and development of biomarkers for various applications, including disease diagnosis, drug discovery, and precision medicine. Nanomosaic is the first commercial entity to leverage the power of nanoneedles for protein detection and quantification, enabling the development of assays for biomarker discovery and validation. With their proprietary technology, they offer rapid custom assay development and push the frontier of biomarker discovery and diagnostics. The company was founded by John J. Boyce, Qimin Quan, and Philippe Mourere has been the CEO since 2023.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Anurag Kondapalli via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Delphibio LLC | Founder | ||
| SEQUENOM, INC. | Medical Specialties | Sales & Marketing | |
GnuBIO, Inc.
 GnuBIO, Inc. Medical SpecialtiesHealth Technology GnuBIO, Inc. develops life science research and clinical diagnostics products. It develops a droplet-based DNA sequencing technology that integrates the entire sample preparation workflow on a chip, from sample capture, PCR, and sequencing to informatics for researchers and clinicians. The company was founded by David A. Weitz, John J. Boyce, IV and Michael P. Weiner and is headquartered in Cambridge, MA. | Medical Specialties | Founder | |
Stilla Technologies SA
 Stilla Technologies SA Miscellaneous Commercial ServicesCommercial Services Stilla Technologies SA operates as a biotechnology company that focuses on the development genetic tests. It provides crystal digital PCR, a next-generation technology for absolute quantification of nucleic acids. The company was founded by Remi Dangla, Etienne Fradet and Clement Gay in 2013 and is headquartered in Villejuif, France. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 8 |
| France | 2 |
Sectorielle
| Health Technology | 5 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 5 |
| Founder | 4 |
| Sales & Marketing | 3 |
| Chief Executive Officer | 3 |
| President | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Anurag Kondapalli
- Connexions Sociétés
